Lisa M. Eubanks, Ph.D. - Publications

Affiliations: 
2002 University of Utah, Salt Lake City, UT 
Area:
Biochemistry, Molecular Biology

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Zhou B, Eubanks LM, Jacob NT, Ellis B, Roberts AJ, Janda KD. Studies towards the improvement of an anti-cocaine monoclonal antibody for treatment of acute overdose. Bioorganic & Medicinal Chemistry Letters. PMID 27599743 DOI: 10.1016/j.bmcl.2016.08.081  0.96
2016 Jacob NT, Lockner JW, Schlosburg JE, Ellis BA, Eubanks LM, Janda KD. Investigations of Enantiopure Nicotine Haptens using an Adjuvanting Carrier in Anti-Nicotine Vaccine Development. Journal of Medicinal Chemistry. PMID 26918428 DOI: 10.1021/acs.jmedchem.5b01676  0.96
2015 Globisch D, Specht S, Pfarr KM, Eubanks LM, Hoerauf A, Janda KD. Litomosoides sigmodontis: A jird urine metabolome study. Bioorganic & Medicinal Chemistry Letters. 25: 5804-7. PMID 26573416 DOI: 10.1016/j.bmcl.2015.10.037  0.96
2014 Eubanks LM, Ellis BA, Cai X, Schlosburg JE, Janda KD. A human recombinant monoclonal antibody to cocaine: Preparation, characterization and behavioral studies. Bioorganic & Medicinal Chemistry Letters. 24: 4664-6. PMID 25205191 DOI: 10.1016/j.bmcl.2014.08.035  0.96
2013 Silhár P, Eubanks LM, Seki H, Pellett S, Javor S, Tepp WH, Johnson EA, Janda KD. Targeting botulinum A cellular toxicity: a prodrug approach. Journal of Medicinal Chemistry. 56: 7870-9. PMID 24127873 DOI: 10.1021/jm400873n  0.96
2011 Eubanks LM, Stowe GN, De Lamo Marin S, Mayorov AV, Hixon MS, Janda KD. Identification of α2 macroglobulin as a major serum ghrelin esterase. Angewandte Chemie (International Ed. in English). 50: 10699-702. PMID 21928452 DOI: 10.1002/anie.201104512  0.96
2011 Salzameda NT, Eubanks LM, Zakhari JS, Tsuchikama K, DeNunzio NJ, Allen KN, Hixon MS, Janda KD. A cross-over inhibitor of the botulinum neurotoxin light chain B: a natural product implicating an exosite mechanism of action. Chemical Communications (Cambridge, England). 47: 1713-5. PMID 21203627 DOI: 10.1039/c0cc04078a  0.96
2010 Eubanks LM, Silhár P, Salzameda NT, Zakhari JS, Xiaochuan F, Barbieri JT, Shoemaker CB, Hixon MS, Janda KD. Identification of a Natural Product Antagonist against the Botulinum Neurotoxin Light Chain Protease. Acs Medicinal Chemistry Letters. 1: 268-272. PMID 20959871 DOI: 10.1021/ml100074s  0.96
2010 Gloeckner C, Garner AL, Mersha F, Oksov Y, Tricoche N, Eubanks LM, Lustigman S, Kaufmann GF, Janda KD. Repositioning of an existing drug for the neglected tropical disease Onchocerciasis. Proceedings of the National Academy of Sciences of the United States of America. 107: 3424-9. PMID 20142509 DOI: 10.1073/pnas.0915125107  0.96
2009 Lowery CA, Abe T, Park J, Eubanks LM, Sawada D, Kaufmann GF, Janda KD. Revisiting AI-2 quorum sensing inhibitors: direct comparison of alkyl-DPD analogues and a natural product fimbrolide. Journal of the American Chemical Society. 131: 15584-5. PMID 19824634 DOI: 10.1021/ja9066783  0.96
2009 Fischer A, Nakai Y, Eubanks LM, Clancy CM, Tepp WH, Pellett S, Dickerson TJ, Johnson EA, Janda KD, Montal M. Bimodal modulation of the botulinum neurotoxin protein-conducting channel. Proceedings of the National Academy of Sciences of the United States of America. 106: 1330-5. PMID 19164566 DOI: 10.1073/pnas.0812839106  0.96
2008 Willis B, Eubanks LM, Dickerson TJ, Janda KD. The strange case of the botulinum neurotoxin: using chemistry and biology to modulate the most deadly poison. Angewandte Chemie (International Ed. in English). 47: 8360-79. PMID 18844202 DOI: 10.1002/anie.200705531  0.96
2008 Willis B, Eubanks LM, Wood MR, Janda KD, Dickerson TJ, Lerner RA. Biologically templated organic polymers with nanoscale order. Proceedings of the National Academy of Sciences of the United States of America. 105: 1416-9. PMID 18216240 DOI: 10.1073/pnas.0711308105  0.96
2007 Eubanks LM, Dickerson TJ. Investigating novel therapeutic targets and molecular mechanisms to treat botulinum neurotoxin A intoxication. Future Microbiology. 2: 677-87. PMID 18041908 DOI: 10.2217/17460913.2.6.677  0.96
2007 Brogan AP, Eubanks LM, Koob GF, Dickerson TJ, Janda KD. Antibody-catalyzed oxidation of delta(9)-tetrahydrocannabinol. Journal of the American Chemical Society. 129: 3698-702. PMID 17335216 DOI: 10.1021/ja070022m  0.96
2007 Eubanks LM, Dickerson TJ, Janda KD. Technological advancements for the detection of and protection against biological and chemical warfare agents. Chemical Society Reviews. 36: 458-70. PMID 17325785 DOI: 10.1039/b615227a  0.96
2007 Eubanks LM, Hixon MS, Jin W, Hong S, Clancy CM, Tepp WH, Baldwin MR, Malizio CJ, Goodnough MC, Barbieri JT, Johnson EA, Boger DL, Dickerson TJ, Janda KD. An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists. Proceedings of the National Academy of Sciences of the United States of America. 104: 2602-7. PMID 17293454 DOI: 10.1073/pnas.0611213104  0.96
2006 Eubanks LM, Rogers CJ, Beuscher AE, Koob GF, Olson AJ, Dickerson TJ, Janda KD. A molecular link between the active component of marijuana and Alzheimer's disease pathology. Molecular Pharmaceutics. 3: 773-7. PMID 17140265 DOI: 10.1021/mp060066m  0.96
2006 Rogers CJ, Eubanks LM, Dickerson TJ, Janda KD. Unexpected acetylcholinesterase activity of cocaine esterases. Journal of the American Chemical Society. 128: 15364-5. PMID 17131989 DOI: 10.1021/ja066241+  0.96
2006 Boldt GE, Eubanks LM, Janda KD. Identification of a botulinum neurotoxin A protease inhibitor displaying efficacy in a cellular model. Chemical Communications (Cambridge, England). 3063-5. PMID 16855686 DOI: 10.1039/b603099h  0.96
2005 Eubanks LM, Dickerson TJ, Janda KD. Vitamin B2-mediated cellular photoinhibition of botulinum neurotoxin A. Febs Letters. 579: 5361-4. PMID 16198354 DOI: 10.1016/j.febslet.2005.08.072  0.96
2004 Scholte AA, Eubanks LM, Poulter CD, Vederas JC. Synthesis and biological activity of isopentenyl diphosphate analogues. Bioorganic & Medicinal Chemistry. 12: 763-70. PMID 14759736 DOI: 10.1016/j.bmc.2003.11.033  0.96
2003 Eubanks LM, Poulter CD. Rhodobacter capsulatus 1-deoxy-D-xylulose 5-phosphate synthase: steady-state kinetics and substrate binding. Biochemistry. 42: 1140-9. PMID 12549936 DOI: 10.1021/bi0205303  0.96
2002 Mu Y, Eubanks LM, Poulter CD, Gibbs RA. Coupling of isoprenoid triflates with organoboron nucleophiles: synthesis and biological evaluation of geranylgeranyl diphosphate analogues. Bioorganic & Medicinal Chemistry. 10: 1207-19. PMID 11886785 DOI: 10.1016/S0968-0896(01)00390-X  0.96
2001 Hahn FM, Eubanks LM, Testa CA, Blagg BS, Baker JA, Poulter CD. 1-Deoxy-D-xylulose 5-phosphate synthase, the gene product of open reading frame (ORF) 2816 and ORF 2895 in Rhodobacter capsulatus. Journal of Bacteriology. 183: 1-11. PMID 11114895 DOI: 10.1128/JB.183.1.1-11.2001  0.96
1996 Mu Y, Gibbs RA, Eubanks LM, Poulter CD. Cuprate-Mediated Synthesis and Biological Evaluation of Cyclopropyl- and tert-Butylfarnesyl Diphosphate Analogs. The Journal of Organic Chemistry. 61: 8010-8015. PMID 11667783  0.96
1996 Mu Y, Gibbs RA, Eubanks LM, Poulter CD. Cuprate-mediated synthesis and biological evaluation of cyclopropyl- and tert-butylfarnesyl diphosphate analogs Journal of Organic Chemistry. 61: 8010-8015. DOI: 10.1021/jo9614203  0.96
Show low-probability matches.